Trade Adaptive Biotechnologies Corporation - ADPT CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.05 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.024124% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001901% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 5.71 |
| Open | 5.78 |
| 1-Year Change | 33.18% |
| Day's Range | 5.78 - 5.97 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Nov 29, 2024 | 5.92 | 0.22 | 3.86% | 5.70 | 5.98 | 5.66 |
| Nov 27, 2024 | 5.71 | 0.09 | 1.60% | 5.62 | 5.82 | 5.50 |
| Nov 26, 2024 | 5.64 | 0.04 | 0.71% | 5.60 | 5.91 | 5.28 |
| Nov 25, 2024 | 5.56 | 0.85 | 18.05% | 4.71 | 5.77 | 4.71 |
| Nov 22, 2024 | 4.64 | 0.36 | 8.41% | 4.28 | 4.68 | 4.27 |
| Nov 21, 2024 | 4.35 | 0.01 | 0.23% | 4.34 | 4.47 | 4.25 |
| Nov 20, 2024 | 4.40 | 0.06 | 1.38% | 4.34 | 4.55 | 4.30 |
| Nov 19, 2024 | 4.46 | 0.04 | 0.90% | 4.42 | 4.62 | 4.36 |
| Nov 18, 2024 | 4.64 | -0.19 | -3.93% | 4.83 | 5.08 | 4.63 |
| Nov 15, 2024 | 5.05 | -0.51 | -9.17% | 5.56 | 5.56 | 5.05 |
| Nov 14, 2024 | 5.55 | -0.26 | -4.48% | 5.81 | 5.81 | 5.51 |
| Nov 13, 2024 | 5.83 | -0.11 | -1.85% | 5.94 | 6.03 | 5.81 |
| Nov 12, 2024 | 5.91 | -0.28 | -4.52% | 6.19 | 6.46 | 5.87 |
| Nov 11, 2024 | 6.48 | 0.64 | 10.96% | 5.84 | 6.68 | 5.84 |
| Nov 8, 2024 | 5.82 | -0.06 | -1.02% | 5.88 | 6.33 | 5.57 |
| Nov 7, 2024 | 5.61 | -0.10 | -1.75% | 5.71 | 6.00 | 5.49 |
| Nov 6, 2024 | 5.72 | 0.05 | 0.88% | 5.67 | 5.77 | 5.44 |
| Nov 5, 2024 | 5.57 | 0.53 | 10.52% | 5.04 | 5.57 | 5.03 |
| Nov 4, 2024 | 5.23 | -0.02 | -0.38% | 5.25 | 5.51 | 5.14 |
| Nov 1, 2024 | 5.29 | 0.47 | 9.75% | 4.82 | 5.30 | 4.80 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Adaptive Biotechnologies Corporation Company profile
About Adaptive Biotechnologies Corp
Adaptive Biotechnologies Corporation is a commercial-stage company. The Company is focused on using the biology of the adaptive immune system to develop the diagnosis and treatment of disease. Its immune medicine platform combines a suite of chemistry, biology and machine learning to generate clinical immunomics data to decode the adaptive immune system. Its commercial research products include immunoSEQ and immunoSEQ T-MAP. immunoSEQ utilizes bias-controlled polymerase chain reaction (PCR) to sequence immune receptors from deoxyribonucleic (DNA). Its clonoSEQ diagnostic test detects and monitors the number of cancer cells that are present in a patient’s body during and after treatment, known as minimal residual disease (MRD). It uses its T cell receptor (TCR)-Antigen Map to develop research solutions and diagnostic products, such as immunoSEQ T-MAP and T-Detect. It also focuses on developing immune-mediated therapies in oncology and other disease areas.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Adaptive Biotechnologies Corp revenues increased 57% to $154.3M. Net loss increased 42% to $207.3M. Revenues reflect Sequencing revenue segment increase of 90% to $78.9M, Development revenue segment increase of 32% to $75.4M. Higher net loss reflects Research and development - Balancing increase of 19% to $128.3M (expense), General and administrative - Balancing increase of 47% to $59.7M (expense).
| Industry: | Bio Diagnostics & Testing |
1165 Eastlake Ave E
SEATTLE
WASHINGTON 98109
US
News
Shiba Inu coin price prediction 2030: could Shiba Inu coin reach $1? Third party price target
Can Shiba Inu reinvent itself to become a worthy long-term investment?
16:41, 28 November 2024
Gold price predictions for the next five years: Third party data round up
Explore the future of gold prices and whether the yellow metal will continue its upward trend in the coming years.
15:17, 18 November 2024
Trump trades charge as Bitcoin hits $US80,000
Bitcoin hits $80,000 amid expectations of fiscal stimulus, lower regulatory risks, and resilient US economy.
10:48, 13 November 2024
Australian jobs data expected to point to solid labour market conditions
Australian labour market and wage data to reveal job growth resilience, shaping RBA rate cut expectations and impacting AUD amidst global economic shifts.
10:16, 13 November 2024
FOMC cuts interest rates as expected and sticks to its line on future policy
The FOMC cut interest rates by 25 basis points at its November meeting, aligning with expectations. Wall Street hit record highs following the decision, with tech stocks leading the rally. Markets are pricing in a probable December cut amid resilient economic indicators.
13:33, 8 November 2024
FOMC and BOE preview: further rate cuts expected
Both the Federal Reserve and the Bank of England are expected to cut rates further when they meet later this week.
14:14, 5 November 2024
RBA meeting preview: No change to policy expected as inflation fight continues
The Reserve Bank of Australia is expected to keep its cash rate on hold at 4.35% when it announces its policy decision at 2.30PM on the 5th of November, 2024. Despite ongoing evidence of soft demand, upside risks to inflation are likely to remain the central bank’s primary concern.
13:35, 4 November 2024People also watch
Still looking for a broker you can trust?
Join the 660,000+ traders worldwide that chose to trade with Capital.com